about
Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.The contribution of genetically determined oxidation status to inter-individual variation in phenacetin dispositionXenobiotics shape the physiology and gene expression of the active human gut microbiome.Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach.Identification of phenacetin metabolites in human urine after administration of phenacetin-C2H3: Measurement of futile metabolic deacetylation via HPLC/MS-SPE-NMR and HPLC-ToF MS
P2860
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh-hant
name
On the pharmacokinetics of phenacetin in man.
@en
On the pharmacokinetics of phenacetin in man.
@nl
type
label
On the pharmacokinetics of phenacetin in man.
@en
On the pharmacokinetics of phenacetin in man.
@nl
prefLabel
On the pharmacokinetics of phenacetin in man.
@en
On the pharmacokinetics of phenacetin in man.
@nl
P356
P1476
On the pharmacokinetics of phenacetin in man.
@en
P2093
J Raaflaub
U C Dubach
P2888
P304
P356
10.1007/BF00567125
P577
1975-04-01T00:00:00Z